As ADCs expand into new indications—including rare cancers and potential autoimmune applications—regulatory pathways continue to adapt. ICON’s regulatory expert, Eilidh Mayer, examines how accelerated approvals, orphan ...
Please use the form below to speak to us about your service requirements. We will respond within 2 working days.
You should use our Submit RFP form to submit a services proposal request. Select the appropriate form if you are interested in careers, are an investigator or investor, or have a media enquiry.
Fields marked with an asterisk (*) are required.
